Fast Growing Pharmaceutical Company Bringing Products to Market to Improve Patient Access To Medicine And Innovation


Fosun Pharma USA Inc. is a wholly owned subsidiary of Fosun Pharma with a focus on building a fully integrated innovative biopharmaceutical company focused on the US market. With the backing of one of the strongest Pharma players in China, Fosun Pharma USA is actively looking to partner with late development stage companies globally to build or support the US commercialization of product for unmet medical needs.


Innovative Medicines

Innovative R&D is the core driver
for sustainable growth of Fosun Pharma USA Inc.

FUSION BioVenture

Fosun Pharma US Innovation Hub (FUSION BioVenture) is an incubation, innovation, and strategic investment platform of Fosun Pharma

Established Medicines

A leading player in specialty generics and high barrier, complex and innovative 505b(2) products

In Vitro Diagnostics

Industry-leading solutions for medical diagnosis. Offering Your Laboratory Easy-to-Use, High Quality and Reliable Assays and Systems


Seeking Partnership Opportunities

We are now looking for late development stage (phase 2 and beyond) or commercial stage innovative products to in-license/partner or acquire for the USA market. While we can facilitate partnership with our parent company for the Chinese market, our clear focus is on US rights for innovative biopharmaceuticals.